Maria Clara Arbelaez1, Noel Alpins2, Shwetabh Verma2, George Stamatelatos2, Juan Guillermo Arbelaez2, Samuel Arba-Mosquera2. 1. From the Muscat Eye Laser Center (M.C. Arbelaez, J.G. Arbelaez), Muscat, Oman; NewVision Clinics (Alpins, Stamatelatos) and Assort Surgical Management Systems (Alpins, Stamatelatos), Melbourne, Australia; Research and Development (Verma, Arba-Mosquera), Schwind eye-tech-solutions GmbH & Co. KG, Kleinostheim, Experimental Radiation Oncology (Verma), University Medical Center Mannheim, Heidelberg University, Mannheim, the Interdisciplinary Center for Scientific Computing (Verma), and the Central Institute for Computer Engineering (Verma), Heidelberg University, Heidelberg, Germany. Electronic address: drmaria@omantel.net.om. 2. From the Muscat Eye Laser Center (M.C. Arbelaez, J.G. Arbelaez), Muscat, Oman; NewVision Clinics (Alpins, Stamatelatos) and Assort Surgical Management Systems (Alpins, Stamatelatos), Melbourne, Australia; Research and Development (Verma, Arba-Mosquera), Schwind eye-tech-solutions GmbH & Co. KG, Kleinostheim, Experimental Radiation Oncology (Verma), University Medical Center Mannheim, Heidelberg University, Mannheim, the Interdisciplinary Center for Scientific Computing (Verma), and the Central Institute for Computer Engineering (Verma), Heidelberg University, Heidelberg, Germany.
Abstract
PURPOSE: To evaluate clinical outcomes of laser in situ keratomileusis (LASIK) with an aberration-neutral profile centered on the estimated visual axis (considering 70% of the pupil offset toward the corneal vertex) comparing vector planning with manifest refraction planning for the treatment of myopic astigmatism. SETTING: Muscat Eye Laser Center, Muscat, Sultanate of Oman, Muscat, Oman. DESIGN: Retrospective case series. METHODS: The outcomes were evaluated at a 6-month follow-up in eyes showing ocular residual astigmatism (ORA) over 0.75 diopters (D) preoperatively. RESULTS: Eighty-five treatments were based on manifest astigmatism (preoperative sphere -2.11 D ± 1.3 [SD], cylinder -0.90 ± 1.0 D), and 79 treatments were based on vector planning (preoperative sphere -2.46 ± 1.5 D, cylinder -0.78 ± 0.79 D). At a 6-month follow-up, 128 patients (164 eyes) were evaluated and no significant differences were observed between the 2 groups in terms of difference between corrected distance visual acuity and uncorrected distance visual acuity (UDVA) (P = .1, t test and Fisher exact test Snellen lines 1 or better, P = .4) and postoperative UDVA (P = .05, t test and Fisher exact test for UDVA 20/16 or better, P = .3). Significant differences were observed between the 2 groups in terms of achieved spherical equivalent (P = .04), corneal toricity, and ORA (P < .001, t test and Fisher exact test for ORA ≤0.75 D, P < .001). CONCLUSION: Performing LASIK for myopic astigmatism with the vector planning approach resulted in comparable visual outcomes to manifest refraction planning.
PURPOSE: To evaluate clinical outcomes of laser in situ keratomileusis (LASIK) with an aberration-neutral profile centered on the estimated visual axis (considering 70% of the pupil offset toward the corneal vertex) comparing vector planning with manifest refraction planning for the treatment of myopic astigmatism. SETTING: Muscat Eye Laser Center, Muscat, Sultanate of Oman, Muscat, Oman. DESIGN: Retrospective case series. METHODS: The outcomes were evaluated at a 6-month follow-up in eyes showing ocular residual astigmatism (ORA) over 0.75 diopters (D) preoperatively. RESULTS: Eighty-five treatments were based on manifest astigmatism (preoperative sphere -2.11 D ± 1.3 [SD], cylinder -0.90 ± 1.0 D), and 79 treatments were based on vector planning (preoperative sphere -2.46 ± 1.5 D, cylinder -0.78 ± 0.79 D). At a 6-month follow-up, 128 patients (164 eyes) were evaluated and no significant differences were observed between the 2 groups in terms of difference between corrected distance visual acuity and uncorrected distance visual acuity (UDVA) (P = .1, t test and Fisher exact test Snellen lines 1 or better, P = .4) and postoperative UDVA (P = .05, t test and Fisher exact test for UDVA 20/16 or better, P = .3). Significant differences were observed between the 2 groups in terms of achieved spherical equivalent (P = .04), corneal toricity, and ORA (P < .001, t test and Fisher exact test for ORA ≤0.75 D, P < .001). CONCLUSION: Performing LASIK for myopic astigmatism with the vector planning approach resulted in comparable visual outcomes to manifest refraction planning.